Albemarle Corp. vs Hims and Hers Health Inc — how do they compare? Albemarle Corp. trades at $131.2 (market cap $15.27B), while Hims and Hers Health Inc trades at $30.66 (market cap $7.12B). The key difference: Albemarle Corp. is far larger — about 2.1× Hims and Hers Health Inc's market cap, and Albemarle Corp. pays a 1.27% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals.
| ALB | HIMS | |
|---|---|---|
Market Cap | $15.27B | $7.12B |
Sector | Basic Materials | Health |
52-Week High | $215.62 | $62.76 |
52-Week Low | $72.58 | $14.52 |
Enterprise Value | $17.75B | $7.82B |
Dividend Yield | 1.27% | — |
Trailing returns across standard periods
Latest headlines on both assets
Albemarle is the world's largest lithium producer. Our outlook for robust lithium demand is predicated upon increased demand for electric vehicle batteries. Albemarle produces lithium from its salt brine deposits in Chile and the U.S. and its hard rock joint venture mines in Australia. Albemarle is also a global leader in the production of bromine, used in flame retardants. The company is also a major producer of oil refining catalysts.
Read more on ALB →Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →